Warfarin prevails for stroke prevention in atrial fibrillation-even in octogenarians

被引：3
|
作者：
Albers, Gregory W. [1 ]
机构：
[1] Stanford Univ, Med Ctr, Stanford Stroke Ctr, Palo Alto, CA 94304 USA
来源：
LANCET NEUROLOGY | 2007年 / 6卷 / 10期
关键词：
D O I：
10.1016/S1474-4422(07)70227-2
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：844 / 846
页数：3
相关论文
共 50 条
  • [31] Edoxaban or standard therapy with warfarin for stroke prevention in patients with atrial fibrillation
    Plitt, Anna
    Giugliano, Robert P.
    FUTURE CARDIOLOGY, 2014, 10 (02) : 153 - 155
  • [32] Economic Evaluation of Warfarin, Dabigatran, Rivaroxaban, and Apixaban for Stroke Prevention in Atrial Fibrillation
    Torbjørn Wisløff
    Gunhild Hagen
    Marianne Klemp
    PharmacoEconomics, 2014, 32 : 601 - 612
  • [33] A Multicentre Experience of Novel Anticoagulation and Warfarin for Use for Stroke Prevention in Atrial Fibrillation
    Navaratnam, R.
    Bolkim, D.
    Sundram, R.
    Jaafar, N.
    Zaimudin, F. W.
    Rebo, R.
    Omar, R.
    Narasamuloo, K. R.
    Shah, W. F. Wan Rahimi
    Tan, B. M.
    Krishinan, S.
    Lim, M. S. H.
    Tiong, L. L.
    Ong, T. K.
    Fong, A. Y. Y.
    Latif, N. A. Abdul
    Chai, H. J.
    Tan, Y. S.
    Lim, A. M. W.
    Lim, C. L.
    Chua, A. T. T.
    Ahmad, N. S.
    Kwong, C. I.
    Yap, L. B.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 249 : S42 - S42
  • [34] Economic Evaluation of Warfarin, Dabigatran, Rivaroxaban, and Apixaban for Stroke Prevention in Atrial Fibrillation
    Wisloff, Torbjorn
    Hagen, Gunhild
    Klemp, Marianne
    PHARMACOECONOMICS, 2014, 32 (06) : 601 - 612
  • [35] COST-EFFECTIVENESS OF RIVAROXABAN COMPARED WITH WARFARIN FOR STROKE PREVENTION IN ATRIAL FIBRILLATION
    Kapur, A. K.
    Chatzitheofilou, I
    Schang, L. K.
    VALUE IN HEALTH, 2012, 15 (04) : A122 - A122
  • [36] Rivaroxaban Vs Warfarin for Stroke Prevention in Patients With Atrial Fibrillation Undergoing TAVR
    Okoh, Alexis K.
    Singh, Swaiman
    Khakwani, Zain
    Chen, Chunguang
    Russo, Mark
    Cohen, Marc
    JACC-CARDIOVASCULAR INTERVENTIONS, 2020, 13 (04) : S51 - S52
  • [37] Cost-Effectiveness of Dabigatran Compared With Warfarin for Stroke Prevention in Atrial Fibrillation
    Freeman, James V.
    Zhu, Ruo P.
    Owens, Douglas K.
    Garber, Alan M.
    Hutton, David W.
    Go, Alan S.
    Wang, Paul J.
    Turakhia, Mintu P.
    ANNALS OF INTERNAL MEDICINE, 2011, 154 (01) : 1 - U129
  • [38] Cost-Effectiveness of Apixaban Compared with Warfarin for Stroke Prevention in Atrial Fibrillation
    Lee, Soyon
    Mullin, Rachel
    Blazawski, Jon
    Coleman, Craig I.
    PLOS ONE, 2012, 7 (10):
  • [39] Choice of antithrombotic therapy for stroke prevention in atrial fibrillation - Warfarin, aspirin, or both?
    Albers, GW
    ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (14) : 1487 - 1491
  • [40] Dabigatran Compared With Warfarin for Stroke Prevention With Atrial Fibrillation: Experience in Hong Kong
    Ho, Jason C. S.
    Chang, Andy M.
    Yan, Bryan P.
    Yu, Cheuk Man
    Lam, Yat Yin
    Lee, Vivian W. Y.
    CLINICAL CARDIOLOGY, 2012, 35 (12) : E40 - E45
12345